Viewing Study NCT06784193

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:02 AM
Ignite Modification Date: 2026-01-05 @ 6:32 PM
Study NCT ID: NCT06784193
Status: RECRUITING
Last Update Posted: 2025-10-10
First Post: 2025-01-14
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
Sponsor: Olema Pharmaceuticals, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced or Metastatic ER+ HER2- Breast Cancer (mBC) View
None Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) View
None Advanced or Metastatic Castration-Resistant Prostate Cancer (mCRPC) View
None Metastatic Breast Cancer View
None Fulvestrant View
None Palazestrant View
Keywords:

Keywords

Keyword Brief Keyword Text View
None KAT6 Inhibitor View
None Histone Acetyltransferase (HAT) Inhibitor View
None Epigenetic View